Slovenia

Slovenia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.84 (0.73 - 0.95) 2019 Modelled IHME
0.89 (0.79 - 1) 2018 Modelled IHME
0.91 (0.79 - 1.03) 2017 Modelled IHME
0.9 (0.79 - 1.02) 2016 Modelled IHME
0.9 (0.77 - 1.02) 2015 Modelled IHME
0.9 (0.78 - 1.02) 2014 Modelled IHME
0.92 (0.80 - 1.04) 2013 Modelled IHME
0.93 (0.82 - 1.06) 2012 Modelled IHME
0.95 (0.84 - 1.08) 2011 Modelled IHME
0.97 (0.84 - 1.11) 2010 Modelled IHME
0.98 (0.85 - 1.12) 2009 Modelled IHME
0.99 (0.87 - 1.12) 2008 Modelled IHME
1 (0.87 - 1.13) 2007 Modelled IHME
1.01 (0.87 - 1.15) 2006 Modelled IHME
1.03 (0.87 - 1.17) 2005 Modelled IHME
1.04 (0.89 - 1.18) 2004 Modelled IHME
1.05 (0.91 - 1.19) 2003 Modelled IHME
1.07 (0.92 - 1.21) 2002 Modelled IHME
1.08 (0.93 - 1.23) 2001 Modelled IHME
1.09 (0.93 - 1.25) 2000 Modelled IHME
1.1 (0.94 - 1.26) 1999 Modelled IHME
1.12 (0.95 - 1.28) 1998 Modelled IHME
1.13 (0.96 - 1.29) 1997 Modelled IHME
1.14 (0.96 - 1.30) 1996 Modelled IHME
1.14 (0.96 - 1.31) 1995 Modelled IHME
1.14 (0.97 - 1.31) 1994 Modelled IHME
1.14 (0.97 - 1.30) 1993 Modelled IHME
1.14 (0.97 - 1.30) 1992 Modelled IHME
1.13 (0.96 - 1.29) 1991 Modelled IHME
1.13 (0.95 - 1.29) 1990 Modelled IHME
1.07 (0.15 - 8.32) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2019 Modelled IHME
0.07 (0.05 - 0.09) 2018 Modelled IHME
0.07 (0.05 - 0.09) 2017 Modelled IHME
0.07 (0.05 - 0.09) 2016 Modelled IHME
0.07 (0.05 - 0.09) 2015 Modelled IHME
0.06 (0.05 - 0.08) 2014 Modelled IHME
0.06 (0.04 - 0.08) 2013 Modelled IHME
0.05 (0.04 - 0.06) 2012 Modelled IHME
0.04 (0.03 - 0.06) 2011 Modelled IHME
0.04 (0.03 - 0.05) 2010 Modelled IHME
0.04 (0.03 - 0.05) 2009 Modelled IHME
0.04 (0.03 - 0.05) 2008 Modelled IHME
0.04 (0.02 - 0.05) 2007 Modelled IHME
0.04 (0.02 - 0.05) 2006 Modelled IHME
0.03 (0.02 - 0.05) 2005 Modelled IHME
0.04 (0.02 - 0.05) 2004 Modelled IHME
0.04 (0.03 - 0.05) 2003 Modelled IHME
0.04 (0.03 - 0.05) 2002 Modelled IHME
0.04 (0.03 - 0.06) 2001 Modelled IHME
0.05 (0.04 - 0.07) 2000 Modelled IHME
0.1 (0.07 - 0.14) 1999 Modelled IHME
0.22 (0.15 - 0.30) 1998 Modelled IHME
0.36 (0.25 - 0.48) 1997 Modelled IHME
0.47 (0.33 - 0.64) 1996 Modelled IHME
0.52 (0.36 - 0.71) 1995 Modelled IHME
0.52 (0.37 - 0.71) 1994 Modelled IHME
0.52 (0.36 - 0.70) 1993 Modelled IHME
0.52 (0.36 - 0.69) 1992 Modelled IHME
0.51 (0.35 - 0.67) 1991 Modelled IHME
0.5 (0.34 - 0.65) 1990 Modelled IHME
1.04 (0.14 - 8.39) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
22,244 (18,756 - 25,501) 1990 Modelled IHME
22,400 (19,021 - 25,542) 1991 Modelled IHME
22,506 (19,159 - 25,679) 1992 Modelled IHME
22,574 (19,183 - 25,766) 1993 Modelled IHME
22,614 (19,243 - 25,920) 1994 Modelled IHME
22,638 (19,128 - 26,039) 1995 Modelled IHME
22,589 (19,112 - 25,898) 1996 Modelled IHME
22,429 (19,054 - 25,700) 1997 Modelled IHME
22,202 (18,905 - 25,434) 1998 Modelled IHME
21,953 (18,734 - 25,099) 1999 Modelled IHME
21,728 (18,587 - 24,905) 2000 Modelled IHME
21,513 (18,557 - 24,458) 2001 Modelled IHME
21,278 (18,454 - 24,059) 2002 Modelled IHME
21,037 (18,198 - 23,843) 2003 Modelled IHME
20,804 (17,831 - 23,613) 2004 Modelled IHME
20,596 (17,521 - 23,455) 2005 Modelled IHME
20,414 (17,598 - 23,133) 2006 Modelled IHME
20,244 (17,604 - 22,843) 2007 Modelled IHME
20,081 (17,523 - 22,651) 2008 Modelled IHME
19,916 (17,348 - 22,670) 2009 Modelled IHME
19,738 (17,173 - 22,622) 2010 Modelled IHME
19,488 (17,106 - 22,187) 2011 Modelled IHME
19,164 (16,812 - 21,811) 2012 Modelled IHME
18,842 (16,430 - 21,398) 2013 Modelled IHME
18,608 (16,030 - 21,146) 2014 Modelled IHME
18,535 (15,825 - 21,160) 2015 Modelled IHME
18,703 (16,304 - 21,075) 2016 Modelled IHME
18,863 (16,471 - 21,331) 2017 Modelled IHME
18,456 (16,299 - 20,667) 2018 Modelled IHME
17,487 (15,224 - 19,712) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.08 (4.94 - 10.10) 2019 Modelled IHME
7.01 (4.98 - 9.82) 2018 Modelled IHME
6.92 (5.15 - 9.13) 2017 Modelled IHME
6.82 (5.16 - 8.81) 2016 Modelled IHME
6.87 (5.31 - 8.79) 2015 Modelled IHME
6.66 (5.08 - 8.46) 2014 Modelled IHME
7.27 (5.59 - 9.31) 2013 Modelled IHME
7.54 (5.76 - 9.71) 2012 Modelled IHME
7.49 (5.71 - 9.62) 2011 Modelled IHME
7.82 (5.97 - 9.99) 2010 Modelled IHME
8.43 (6.42 - 10.80) 2009 Modelled IHME
9.8 (7.55 - 12.40) 2008 Modelled IHME
11.3 (8.77 - 14.20) 2007 Modelled IHME
12.3 (9.63 - 15.40) 2006 Modelled IHME
12.4 (9.73 - 15.48) 2005 Modelled IHME
13.3 (10.40 - 16.50) 2004 Modelled IHME
13.9 (10.90 - 17.40) 2003 Modelled IHME
13.5 (10.60 - 17) 2002 Modelled IHME
13.9 (10.80 - 17.30) 2001 Modelled IHME
13.36 (10.50 - 16.60) 2000 Modelled IHME
13.3 (10.40 - 16.50) 1999 Modelled IHME
13 (10.10 - 16.10) 1998 Modelled IHME
12.7 (9.91 - 15.60) 1997 Modelled IHME
12.5 (9.35 - 16.20) 1996 Modelled IHME
12.4 (8.96 - 16.70) 1995 Modelled IHME
12.4 (8.79 - 16.90) 1994 Modelled IHME
12.4 (8.61 - 17.40) 1993 Modelled IHME
12.4 (8.65 - 17.20) 1992 Modelled IHME
12.5 (8.68 - 17.30) 1991 Modelled IHME
12.6 (8.65 - 17.40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
147 (103 - 209) 2019 Modelled IHME
145 (103 - 204) 2018 Modelled IHME
144 (107 - 189) 2017 Modelled IHME
141 (107 - 183) 2016 Modelled IHME
142 (110 - 182) 2015 Modelled IHME
137 (105 - 175) 2014 Modelled IHME
150 (115 - 192) 2013 Modelled IHME
155 (118 - 199) 2012 Modelled IHME
153 (117 - 197) 2011 Modelled IHME
160 (122 - 204) 2010 Modelled IHME
171 (131 - 219) 2009 Modelled IHME
199 (153 - 251) 2008 Modelled IHME
228 (177 - 286) 2007 Modelled IHME
248 (194 - 310) 2006 Modelled IHME
250 (195 - 311) 2005 Modelled IHME
266 (209 - 329) 2004 Modelled IHME
278 (218 - 347) 2003 Modelled IHME
270 (212 - 339) 2002 Modelled IHME
278 (216 - 345) 2001 Modelled IHME
266 (209 - 331) 2000 Modelled IHME
264 (207 - 328) 1999 Modelled IHME
259 (201 - 321) 1998 Modelled IHME
253 (197 - 311) 1997 Modelled IHME
248 (186 - 323) 1996 Modelled IHME
247 (178 - 331) 1995 Modelled IHME
247 (175 - 336) 1994 Modelled IHME
247 (171 - 345) 1993 Modelled IHME
244 (171 - 340) 1992 Modelled IHME
248 (172 - 343) 1991 Modelled IHME
249 (170 - 344) 1990 Modelled IHME
165 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
20 (14 - 28) 2019 Modelled IHME
21 (14 - 29) 2018 Modelled IHME
21 (15 - 29) 2017 Modelled IHME
21 (15 - 29) 2016 Modelled IHME
21 (14 - 29) 2015 Modelled IHME
21 (14 - 29) 2014 Modelled IHME
21 (15 - 29) 2013 Modelled IHME
21 (15 - 29) 2012 Modelled IHME
21 (15 - 30) 2011 Modelled IHME
21 (15 - 30) 2010 Modelled IHME
22 (15 - 30) 2009 Modelled IHME
23 (16 - 31) 2008 Modelled IHME
23 (17 - 32) 2007 Modelled IHME
24 (17 - 33) 2006 Modelled IHME
25 (17 - 34) 2005 Modelled IHME
25 (18 - 34) 2004 Modelled IHME
25 (18 - 34) 2003 Modelled IHME
25 (17 - 34) 2002 Modelled IHME
25 (17 - 34) 2001 Modelled IHME
25 (18 - 34) 2000 Modelled IHME
25 (18 - 34) 1999 Modelled IHME
25 (18 - 34) 1998 Modelled IHME
24 (18 - 33) 1997 Modelled IHME
24 (17 - 33) 1996 Modelled IHME
24 (17 - 33) 1995 Modelled IHME
24 (17 - 33) 1994 Modelled IHME
24 (17 - 33) 1993 Modelled IHME
24 (17 - 33) 1992 Modelled IHME
24 (17 - 33) 1991 Modelled IHME
24 (17 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
85 (65 - 122) 2014 Survey/reported Slovenia National Institute of Public Health, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
62 2016 Survey/reported EMCDDA, 2019
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.22 (0.99 - 1.51) 2019 Modelled IHME
1.21 (0.98 - 1.48) 2018 Modelled IHME
1.2 (0.98 - 1.46) 2017 Modelled IHME
1.2 (0.98 - 1.46) 2016 Modelled IHME
1.2 (0.97 - 1.47) 2015 Modelled IHME
1.21 (0.98 - 1.47) 2014 Modelled IHME
1.21 (0.99 - 1.47) 2013 Modelled IHME
1.22 (0.99 - 1.48) 2012 Modelled IHME
1.22 (1 - 1.48) 2011 Modelled IHME
1.23 (1 - 1.49) 2010 Modelled IHME
1.23 (1 - 1.49) 2009 Modelled IHME
1.23 (1.01 - 1.51) 2008 Modelled IHME
1.24 (1.01 - 1.53) 2007 Modelled IHME
1.24 (1.01 - 1.54) 2006 Modelled IHME
1.25 (1.01 - 1.55) 2005 Modelled IHME
1.25 (1.02 - 1.55) 2004 Modelled IHME
1.26 (1.03 - 1.55) 2003 Modelled IHME
1.26 (1.03 - 1.55) 2002 Modelled IHME
1.27 (1.04 - 1.55) 2001 Modelled IHME
1.27 (1.03 - 1.55) 2000 Modelled IHME
1.27 (1.03 - 1.55) 1999 Modelled IHME
1.27 (1.03 - 1.54) 1998 Modelled IHME
1.27 (1.03 - 1.55) 1997 Modelled IHME
1.27 (1.03 - 1.55) 1996 Modelled IHME
1.27 (1.03 - 1.55) 1995 Modelled IHME
1.27 (1.03 - 1.55) 1994 Modelled IHME
1.27 (1.03 - 1.56) 1993 Modelled IHME
1.26 (1.02 - 1.56) 1992 Modelled IHME
1.26 (1.02 - 1.55) 1991 Modelled IHME
1.25 (1.01 - 1.54) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
30.5 (26.40 - 34.50) 2014 Modelled Degenhardt L et al, 2017
32.1 (23.60 - 41.60) 2009 Survey/reported EMCDDA
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.1 (0.10 - 0.20) 2013 Survey/reported Kopilovic B PM et al, 2015
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
24,701 (20,000 - 30,369) 1990 Modelled IHME
24,855 (20,057 - 30,556) 1991 Modelled IHME
24,989 (20,244 - 30,794) 1992 Modelled IHME
25,100 (20,410 - 30,840) 1993 Modelled IHME
25,184 (20,434 - 30,730) 1994 Modelled IHME
25,237 (20,402 - 30,852) 1995 Modelled IHME
25,269 (20,442 - 30,775) 1996 Modelled IHME
25,292 (20,528 - 30,782) 1997 Modelled IHME
25,306 (20,578 - 30,732) 1998 Modelled IHME
25,317 (20,592 - 30,771) 1999 Modelled IHME
25,328 (20,613 - 30,807) 2000 Modelled IHME
25,307 (20,644 - 30,976) 2001 Modelled IHME
25,239 (20,644 - 30,965) 2002 Modelled IHME
25,151 (20,548 - 31,064) 2003 Modelled IHME
25,068 (20,416 - 30,983) 2004 Modelled IHME
25,020 (20,316 - 31,049) 2005 Modelled IHME
25,005 (20,401 - 30,896) 2006 Modelled IHME
25,001 (20,369 - 30,810) 2007 Modelled IHME
25,007 (20,369 - 30,562) 2008 Modelled IHME
25,021 (20,340 - 30,375) 2009 Modelled IHME
25,033 (20,360 - 30,311) 2010 Modelled IHME
25,024 (20,439 - 30,246) 2011 Modelled IHME
24,989 (20,391 - 30,352) 2012 Modelled IHME
24,942 (20,350 - 30,318) 2013 Modelled IHME
24,908 (20,228 - 30,264) 2014 Modelled IHME
24,897 (20,126 - 30,405) 2015 Modelled IHME
24,893 (20,323 - 30,211) 2016 Modelled IHME
24,903 (20,314 - 30,284) 2017 Modelled IHME
25,036 (20,367 - 30,606) 2018 Modelled IHME
25,305 (20,634 - 31,275) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.17 (5.74 - 11.30) 2019 Modelled IHME
8.1 (5.87 - 11) 2018 Modelled IHME
8 (6.01 - 10.50) 2017 Modelled IHME
7.87 (6.14 - 9.98) 2016 Modelled IHME
7.92 (6.21 - 10) 2015 Modelled IHME
7.68 (5.97 - 9.80) 2014 Modelled IHME
8.25 (6.46 - 10.60) 2013 Modelled IHME
8.47 (6.65 - 10.80) 2012 Modelled IHME
8.35 (6.48 - 10.60) 2011 Modelled IHME
8.58 (6.64 - 11) 2010 Modelled IHME
8.51 (6.56 - 11) 2009 Modelled IHME
8.43 (6.51 - 11) 2008 Modelled IHME
8.28 (6.38 - 10.80) 2007 Modelled IHME
7.94 (6.13 - 10.30) 2006 Modelled IHME
7.64 (5.92 - 10) 2005 Modelled IHME
8.09 (6.12 - 10.70) 2004 Modelled IHME
8.38 (6.36 - 11.10) 2003 Modelled IHME
8.23 (6.19 - 10.90) 2002 Modelled IHME
8.47 (6.49 - 11.30) 2001 Modelled IHME
8.14 (6.14 - 10.80) 2000 Modelled IHME
8.08 (6.11 - 10.70) 1999 Modelled IHME
7.9 (5.96 - 10.50) 1998 Modelled IHME
7.71 (5.83 - 10.30) 1997 Modelled IHME
7.52 (5.43 - 10.30) 1996 Modelled IHME
7.45 (5.17 - 10.60) 1995 Modelled IHME
7.46 (5.01 - 10.60) 1994 Modelled IHME
7.45 (5.09 - 10.70) 1993 Modelled IHME
7.41 (4.95 - 10.90) 1992 Modelled IHME
7.54 (4.99 - 10.90) 1991 Modelled IHME
7.63 (5.08 - 11) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
169 (119 - 235) 2019 Modelled IHME
168 (122 - 229) 2018 Modelled IHME
166 (125 - 218) 2017 Modelled IHME
163 (127 - 207) 2016 Modelled IHME
164 (128 - 207) 2015 Modelled IHME
158 (123 - 202) 2014 Modelled IHME
170 (133 - 217) 2013 Modelled IHME
174 (137 - 221) 2012 Modelled IHME
171 (133 - 217) 2011 Modelled IHME
175 (135 - 225) 2010 Modelled IHME
173 (133 - 223) 2009 Modelled IHME
171 (132 - 222) 2008 Modelled IHME
167 (129 - 217) 2007 Modelled IHME
160 (123 - 207) 2006 Modelled IHME
153 (119 - 201) 2005 Modelled IHME
162 (123 - 213) 2004 Modelled IHME
168 (127 - 222) 2003 Modelled IHME
164 (124 - 217) 2002 Modelled IHME
169 (129 - 225) 2001 Modelled IHME
162 (122 - 214) 2000 Modelled IHME
161 (122 - 213) 1999 Modelled IHME
157 (119 - 209) 1998 Modelled IHME
153 (116 - 205) 1997 Modelled IHME
150 (108 - 205) 1996 Modelled IHME
148 (103 - 211) 1995 Modelled IHME
148 (99 - 210) 1994 Modelled IHME
148 (101 - 213) 1993 Modelled IHME
147 (98 - 215) 1992 Modelled IHME
149 (99 - 215) 1991 Modelled IHME
150 (100 - 217) 1990 Modelled IHME
184 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
28 (20 - 36) 2019 Modelled IHME
28 (20 - 36) 2018 Modelled IHME
28 (20 - 37) 2017 Modelled IHME
28 (20 - 36) 2016 Modelled IHME
28 (20 - 36) 2015 Modelled IHME
28 (20 - 36) 2014 Modelled IHME
27 (20 - 36) 2013 Modelled IHME
27 (19 - 36) 2012 Modelled IHME
27 (19 - 36) 2011 Modelled IHME
27 (19 - 36) 2010 Modelled IHME
27 (19 - 36) 2009 Modelled IHME
27 (19 - 35) 2008 Modelled IHME
26 (19 - 35) 2007 Modelled IHME
26 (18 - 34) 2006 Modelled IHME
26 (18 - 34) 2005 Modelled IHME
26 (18 - 34) 2004 Modelled IHME
25 (18 - 34) 2003 Modelled IHME
26 (18 - 34) 2002 Modelled IHME
26 (18 - 34) 2001 Modelled IHME
26 (18 - 34) 2000 Modelled IHME
26 (18 - 34) 1999 Modelled IHME
26 (18 - 34) 1998 Modelled IHME
26 (18 - 34) 1997 Modelled IHME
26 (18 - 34) 1996 Modelled IHME
26 (18 - 34) 1995 Modelled IHME
26 (18 - 34) 1994 Modelled IHME
26 (18 - 34) 1993 Modelled IHME
26 (18 - 34) 1992 Modelled IHME
26 (18 - 34) 1991 Modelled IHME
26 (19 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
85 (65 - 122) 2014 Survey/reported Slovenia National Institute of Public Health, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
62 2016 Survey/reported EMCDDA, 2019
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
147
2019
(103 - 209)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
169
2019
(119 - 235)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines